APA Alıntı

Habibi, J., Aroor, A. R., Sowers, J. R., Jia, G., Hayden, M. R., Garro, M., . . . DeMarco, V. G. (2017). Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes. Cardiovasc Diabetol.

Chicago Stili Alıntı

Habibi, Javad, et al. "Sodium Glucose Transporter 2 (SGLT2) Inhibition With Empagliflozin Improves Cardiac Diastolic Function in a Female Rodent Model of Diabetes." Cardiovasc Diabetol 2017.

MLA Alıntı

Habibi, Javad, et al. "Sodium Glucose Transporter 2 (SGLT2) Inhibition With Empagliflozin Improves Cardiac Diastolic Function in a Female Rodent Model of Diabetes." Cardiovasc Diabetol 2017.